PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China.\', \'Department of Clinical Hematology, College of Pharmacy, Third Military Medical University, Chongqing, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.757691
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34630436
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • α-Hemolysin-Aided Oligomerization of the Spike Protein RBD Resulted in Improved Immunogenicity and Neutralization Against SARS-CoV-2 Variants.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all